Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Non-cash Items (2016 - 2019)

Neurocrine Biosciences' Non-cash Items history spans 8 years, with the latest figure at $4.0 million for Q4 2019.

  • For Q4 2019, Non-cash Items rose 2.56% year-over-year to $4.0 million; the TTM value through Dec 2019 reached $4.0 million, up 2.56%, while the annual FY2019 figure was $4.0 million, 2.56% up from the prior year.
  • Non-cash Items reached $4.0 million in Q4 2019 per NBIX's latest filing, up from $3.9 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $4.5 million in Q4 2016 to a low of $3.8 million in Q4 2015.
  • Average Non-cash Items over 5 years is $4.1 million, with a median of $4.0 million recorded in 2019.
  • Peak YoY movement for Non-cash Items: dropped 9.52% in 2015, then grew 18.42% in 2016.
  • A 5-year view of Non-cash Items shows it stood at $3.8 million in 2015, then rose by 18.42% to $4.5 million in 2016, then decreased by 6.67% to $4.2 million in 2017, then fell by 7.14% to $3.9 million in 2018, then increased by 2.56% to $4.0 million in 2019.
  • Per Business Quant, the three most recent readings for NBIX's Non-cash Items are $4.0 million (Q4 2019), $3.9 million (Q4 2018), and $4.2 million (Q4 2017).